glp-1 mash Resmetirom and agonists for MASH: complementary rather than exclusive The Emerging Role of Glucagon-Like
Description
It is worth noting that monoclonal antibody (mAb) therapies as typically used for the treatment of autoimmune diseases can only be formulated for single-use for delivery from an autoinjector

The therapeutic landscape continues to evolve rapidly with the development of dual and triple agonists

If youre on semaglutide but still feel constantly hungry, it may not be about the medicationit could be your bodys way of signaling a need for more nutrition

Zhang Y, Tang C, He Y, Zhang Y, Li Q, Zhang T, Zhao B, Tong A, Zhong Q, Zhong Z (2024) Semaglutide ameliorates Alzheimers disease and restores oxytocin in APP/PS1 mice and human brain organoid models

While early results are promising, further research is necessary to determine their long-term efficacy in managing HS

However, it's crucial to remember that research in this area is still developing, and more studies are needed to confirm these potential benefits and understand any risks
